about
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationMetabolic syndrome and the hepatorenal reflexATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry StudyTransferred inter-cell ischemic preconditioning-induced neuroprotection may be mediated by adenosine A1 receptors.Adenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.Platelet dynamics during natural and pharmacologically induced torpor and forced hypothermiaExtracellular nucleotide and nucleoside signaling in vascular and blood diseaseAMP affects intracellular Ca2+ signaling, migration, cytokine secretion and T cell priming capacity of dendritic cellsEffects of adenosine monophosphate used in combination with L-arginine on female rabbit corpus cavernosum tissueHigh-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase.Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish.Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactionsExtracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.Hyperoxic Exposure of Immature Mice Increases the Inflammatory Response to Subsequent Rhinovirus Infection: Association with Danger Signals.5'-AMP impacts lymphocyte recirculation through activation of A2B receptors.Adenosine production by human B cells and B cell-mediated suppression of activated T cellsTissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord.Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney.Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis.Adenosine-A1 receptor agonist induced hyperalgesic priming type II.Metabolic syndrome and the hepatorenal reflex.Overexpression of diacylglycerol kinase η enhances Gαq-coupled G protein-coupled receptor signaling.Induced and natural regulatory T cells in human cancer.The Importance of astrocyte-derived purines in the modulation of sleep.The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?Immunoregulatory activity of adenosine and its role in human cancer progression.Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects.Inflammasome activators induce fibronectin expression and release in macrophages.Safety issues of compounds acting on adenosinergic signalling.Pharmacological hypothermia: a potential for future stroke therapy?Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Targeting adenosine in cancer immunotherapy: a review of recent progress.Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg).Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke.Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia.
P2860
Q21131166-11E3196C-105D-49A0-BB3D-C362E06A034AQ28073645-B22CE269-541E-4D93-BE76-5B8EBD3008E6Q28550753-14B02B2D-D112-479B-B027-2A07BD60B727Q30406005-B68D1C59-AE8D-48F3-910F-9847CC47A3C6Q30537881-30F0C7D2-84D4-42BF-A443-A7E48512E9B6Q33414555-CCAF3BEA-49F6-470D-8DAB-C452AFACA570Q34047834-15FB021B-40E8-411E-88F4-15EE40C9ED73Q34280067-81E766FB-9DE0-4626-8857-1ABF1A3276FAQ34286586-CE2BB9A6-DC7C-4376-89E6-900B18699317Q34494652-6607668A-A956-4DFF-9F5E-DB2EF0402A13Q35200135-06197BEC-2E70-49BC-AE38-A82AE95E464FQ35897785-0E4095FF-007C-4E6A-8E9F-119229502B84Q35987700-7CA994FC-2459-4B50-8130-4BF8EDDFB1ECQ36310954-2C4DCBB7-0F1C-49B4-B94C-1B7911FF1A7BQ36408152-516BA928-D30C-406B-AC22-80FEEDC109B7Q36923788-C4187EEA-670D-4E60-97BF-016D29969D3AQ36935733-F7E7763D-6D1F-41BE-A8DD-55E68FCC9D83Q36983750-741B50F5-1DE0-4F2C-84C6-98BE8471A2ECQ37032505-DA71F2FD-644B-467F-A7DF-2CAC8BCCD488Q37188515-4A1452E8-AA3F-4FCC-830B-4A18B1535F3BQ37257326-E4EE4188-299D-45DC-83A6-7C1ED6BD9FA0Q37308329-3680EE96-91D5-453F-8852-2C7466AEEEF8Q37604638-6B24CB8C-4801-4F0E-8380-47F1A8347ED4Q37708120-008EB4EE-FCF8-41BB-9BEB-4E59F78BCB0CQ38030976-D43EE1BE-A4DA-433B-A644-AB5B09AB0924Q38048710-EF681DAA-09C3-4FF5-81DC-6471CC1D69DBQ38063159-784E1472-1DC2-4138-8AC3-90057B88AD2DQ38161416-9235456B-21EB-4586-A953-613A7C2FF4D8Q38215678-3F23279E-D6AC-47DB-B724-0E08810BC75BQ38305482-E686BEED-9A91-4CC3-BAB7-16B68AF18971Q38729866-965AABED-3AD1-4C9D-AC24-EF9011A66EA2Q38843185-CBB60129-D67B-41E0-8D91-0227E72198F4Q38851190-51A3A647-922A-42F8-AD73-B5ABC8A5BA81Q39002543-87EB94F5-5EB1-4F8B-B5AF-1B77A545349EQ39133269-9AAFCC81-2AD9-40C2-9350-BB05B9C34071Q39161005-A2451E7C-1CD7-480C-8592-863F31F96762Q39235260-56BDFEF9-BB7A-4F75-84B4-1EEF93C00F72Q39281335-8AFBD07C-4BA0-405A-84DD-F583EA3F6BBBQ39282003-1BB738B0-83DC-40F9-A2CD-CEC069625AC8Q40270472-C2FB5A34-7010-4722-8F85-19AB9F8FA057
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
AMP is an adenosine A1 receptor agonist
@ast
AMP is an adenosine A1 receptor agonist
@en
type
label
AMP is an adenosine A1 receptor agonist
@ast
AMP is an adenosine A1 receptor agonist
@en
prefLabel
AMP is an adenosine A1 receptor agonist
@ast
AMP is an adenosine A1 receptor agonist
@en
P2093
P2860
P356
P1476
AMP is an adenosine A1 receptor agonist
@en
P2093
Emily A Hull-Ryde
Ilia Korboukh
Joseph E Rittiner
Mark J Zylka
Stephen V Frye
William P Janzen
P2860
P304
P356
10.1074/JBC.M111.291666
P407
P577
2012-01-03T00:00:00Z